examine the ability of L-carnitine to modulate cytokine production at higher doses, 200 and 400 ltg/ml, in young donors. The results of these studies showed that in addition to TNF0t, significant production of IL-I and IL-6 was observed. These preliminary studies provide evidence that carnitine may modulate immune functions through the production of selected cytokines.
Introduction
Long-chain fatty acids are a major source for the production of energy in humans. This is particularly true for various organs including the liver, the heart, and the skeletal muscle system. Energy is generated through fl-oxidation of these fatty acids which are transported by carnitine across the mitochondrial membrane. In addition to its role as a carrier for long-chain fatty acids Fig. 1 . No or minimal TNF0 < 10 pg/ml) was produced by cells cultured modulate the production of cytokines by human PBMC. It appears however, that this process of cytokine production is more pronounced in cells of young donors than in cells obtained from old donors. This observation needs to be confirmed by 17 In the present study, the small number of donors has to be taken into consideration before conclusions can be drawn. Nevertheless, one also has to consider that this selection for TNF0 production may be associated with some unique features of the ability of carnitine to modulate the immune response.
